HimalayasHimalayas logo
BillionToOneBI

Clinical Genomics Scientist, Oncology (Part-Time Contractor)

BillionToOne is a precision diagnostics company developing advanced molecular diagnostic tools to make testing more accurate, efficient, and accessible, focusing on prenatal screening and oncology. Their proprietary QCT technology enables counting DNA molecules at a single-count level for improved disease detection.

BillionToOne

Employee count: 501-1000

Salary: 208k-208k USD

Stay safe on Himalayas

Never send money to companies. Jobs on Himalayas will never require payment from applicants.

Ready to redefine what's possible in molecular diagnostics?

Join a team of brilliant, passionate innovators who wake up every day determined to transform healthcare. At BillionToOne, we've built something extraordinary—a culture where transparency fuels trust, collaboration drives breakthroughs, and every voice matters in our mission to make life-changing diagnostics accessible to all. We don't just aim for incremental improvements; we strive to build products that are 10x better than anything that exists today. Our people are our greatest asset:talented scientists, engineers, sales professionals, and visionaries united by an unwavering commitment to changing the standard of care in prenatal and cancer diagnostics. This is where cutting-edge science meets human compassion—every innovation you contribute helps remove fear of unknown from some of life's most critical medical moments. If you're driven by purpose, energized by innovation, and ready to help build the future of precision medicine, this is where you belong.

We are looking for a Clinical Genomics Scientist, Oncology to join and support our Clinical Genomics team. You are responsible for helping with day-to-day commercial reporting operations, including variant interpretation and report drafting. Working closely with the clinical genomics team, you will help scale-up our ever growing reporting needs. This role is a part-time contracting position (10-20 hrs/week) and will report to the Senior Manager, Clinical Genomics, Oncology in a remote-based position. We are looking for someone with long-term engagement interests and able to commit to a minimum of 1 year or longer.
If you have a strong commitment to improving patient care through clear clinical reporting, have experience in somatic variant interpretation and report drafting, enjoy digging into the technical side of the data alongside bioinformatics, and thrive in a fast-paced entrepreneurial environment, this could be a perfect opportunity for you.

Key Responsibilities:

  • Somatic variant interpretation and data review: Perform somatic-based variant interpretation, diving into the literature and databases to classify variants and match treatments for reporting, performing verification as required with BAM file analysis.
  • Clinical report drafting: Carefully draft reports for each requisition primarily using in-house reporting API, working closely with the engineering and QA teams on reporting, and the laboratory directors on report language.

Content curation: Contribute to curation of gene-level content such as domain and critical residue curation.

  • Contribute to oncology R&D: Work closely with the R&D team to help with somatic oncology based projects, providing expertise on variant interpretation, biological pathways/mechanisms, and other gene/variant-level reviews and analyses.

Requirements

  • Ph.D. in Human Genetics, M.S. in Genetic Counseling, or related field
  • 2+ years of experience in somatic variant interpretation based on ACMG/AMP guidelines in a clinical setting (alternatively, 1+ years of germline variant interpretation and 1+ years of somatic variant interpretation experience)
  • Hands-on experience working with human mutation databases (COSMIC, ClinVar, OncoKB), functional annotation sources (dbSNP), and genome browsers (UCSC)
  • Familiarity with IGV and BAM file analysis and data-minded willingness to learn to use basic bioinformatics tools, with technically minded insights
  • Knowledge of cancer somatic mutation and signaling pathways (e.g., which mutations have FDA approved drugs, Phase II/III clinical trials, which mutations are considered “hot targets” for drug development, etc.)
  • Exceptional attention to detail to follow highly detailed SOPs and strong organizational skills to track and manage clinical reporting and product improvement projects
  • Excellent communication skills and ability to work collaboratively with cross-functional teams

Ability to work on Saturday and/or Sunday, in addition to hours during the week.

Benefits And Perks:

  • Working alongside brilliant, kind, passionate and dedicated colleagues, in an empowering environment, toward a global vision, striving for a future in which transformative molecular diagnostics can help millions of patients
  • The ability to indirectly or directly change the lives of hundreds of thousands patients

For this position, the target hourly rate is: $100/hour.

BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

For more information about how we protect your information, we encourage you to review our Privacy Policy.

About BillionToOne

BillionToOne is a next-generation molecular diagnostics company on a mission to make powerful, accurate diagnostic tests accessible to everyone. Our revolutionary QCT molecular counting technology enhances disease detection resolution by over a thousandfold using cell-free DNA—a breakthrough that's already transformed the lives of over half a million patients worldwide.

Our Impact: We've pioneered game-changing diagnostic solutions that are redefining industry standards. Unity Complete™ stands as the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. In oncology, our Northstar® liquid biopsy test uniquely combines treatment selection with real-time monitoring, giving oncologists unprecedented precision in cancer care.

Our Growth: From $0 to $125 million in Annual Recurring Revenue in just four years. We've raised close to $400 million in funding, including a $130 million Series D round in June 2024, achieving a valuation of over $1 billion. This backing comes from world-class investors including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest.

Our Recognition: Forbes recently named us one of America's Best Startup Employers for 2025, and we were awarded Great Place to Work certification in 2024—with an incredible 100% of our people reporting they are willing to give extra to get the job done. These honors recognize not just our innovation but the exceptional culture we've cultivated—one that remains authentically collaborative and transparent even as we've scaled.

Our Future: Headquartered in Menlo Park with facilities in Union City, California, we're continuing to push the boundaries of what's possible in molecular diagnostics. Recent clinical outcomes data for Unity Fetal Risk Screen and new advances in cancer diagnostics prove we're just getting started.

At BillionToOne, you'll join a diverse team of passionate innovators who believe that the best science happens when brilliant minds collaborate openly, think boldly, and never lose sight of the patients whose lives depend on our work.

Ready to help us change the world, one diagnosis at a time?

Learn more at www.billiontoone.com

About the job

Apply before

Posted on

Job type

Full Time

Experience level

Salary

Salary: 208k-208k USD

Location requirements

Open to candidates from all countries.

Hiring timezones

Worldwide

About BillionToOne

Learn more about BillionToOne and their company culture.

View company profile

Through groundbreaking technology, we are revolutionizing molecular diagnostics at BillionToOne. Headquartered in Menlo Park, California, BillionToOne is a precision diagnostics company with a mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patented Quantitative Counting Templates, or QCTs™, represent a significant technological breakthrough, powering our ability to detect and measure tiny and sparse disease-related DNA fragments at the single base-pair level. This innovation is crucial because several common and severe recessive conditions screened for prenatally can be caused by single-base pair alterations. Our QCT technology enables quantifying these tiny variations using cell-free DNA, opening the door to exponential improvements in prenatal screening, liquid biopsy, and beyond. We believe this quantification will unlock transformative advancements in how diseases are detected and managed. The company's QCT molecular counter platform is the only technology that can count DNA molecules at the single-count level with single base-pair precision, increasing the cell-free DNA diagnostics resolution by over 1,000-fold.

Our innovation focus is evident in our flagship products. UNITY Screen™, our commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions (like cystic fibrosis, spinal muscular atrophy, and sickle cell disease) and aneuploidies from a single maternal blood sample, as early as nine weeks into pregnancy, without requiring a paternal sample. This simplifies the testing process and provides timely, precise fetal risk assessments. In 2023, we expanded our innovative approach into oncology with the launch of Northstar™ Select and Northstar™ Response. These pioneering liquid biopsy tests leverage our molecular counting technology for therapy selection and monitoring tumor burden, aiming to transform oncology care. BillionToOne is committed to pushing the boundaries of molecular diagnostics to improve healthcare, with over 500,000 patients having benefited from our precise diagnostic tests. We are dedicated to developing powerful and accurate diagnostic tests that are accessible to all, continually striving to advance healthcare through innovation.

Employee benefits

Learn about the employee benefits and perks provided at BillionToOne.

View benefits

Competitive pay

We offer competitive pay.

Complimentary gym

Stay healthy with our complimentary gym.

EV charging stations

Charge your EV at our charging stations.

COVID testing

Complimentary COVID testing for all employees.

View BillionToOne's employee benefits
Claim this profileBillionToOne logoBI

BillionToOne

View company profile

Similar remote jobs

Here are other jobs you might want to apply for.

View all remote jobs

2 remote jobs at BillionToOne

Explore the variety of open remote roles at BillionToOne, offering flexible work options across multiple disciplines and skill levels.

View all jobs at BillionToOne

Remote companies like BillionToOne

Find your next opportunity by exploring profiles of companies that are similar to BillionToOne. Compare culture, benefits, and job openings on Himalayas.

View all companies

Find your dream job

Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
Himalayas profile for an example user named Frankie Sullivan